Skip to main content

Breo Ellipta Side Effects

Generic name: fluticasone / vilanterol

Medically reviewed by Drugs.com. Last updated on Jul 16, 2023.

Note: This document contains side effect information about fluticasone / vilanterol. Some dosage forms listed on this page may not apply to the brand name Breo Ellipta.

Applies to fluticasone / vilanterol: inhalation powder.

Serious side effects of Breo Ellipta

Along with its needed effects, fluticasone/vilanterol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking fluticasone / vilanterol:

More common

Less common

Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking fluticasone / vilanterol:

Symptoms of overdose

Other side effects of Breo Ellipta

Some side effects of fluticasone / vilanterol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

For Healthcare Professionals

Applies to fluticasone / vilanterol: inhalation powder.

General

The most common adverse reactions are nasopharyngitis, upper respiratory tract infection, headache, and oral candidiasis.[Ref]

Cardiovascular

Common (1% to 10%): Hypertension

Uncommon (0.1% to 1%): Extrasystoles[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea, oral candidiasis, abdominal pain[Ref]

Musculoskeletal

Common (1% to 10%): Back pain, arthralgia, fractures

Postmarketing reports: Muscle spasm[Ref]

Nervous system

Common (1% to 10%): Headache, tremor[Ref]

Other

Common (1% to 10%): Influenza, pyrexia, peripheral edema[Ref]

Respiratory

Common (1% to 10%): Nasopharyngitis, upper respiratory tract infection, oropharyngeal candidiasis, chronic obstructive pulmonary disease (COPD), pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, pharyngitis, oropharyngitis fungal

Frequency not reported: Paradoxical bronchospasm[Ref]

Hypersensitivity

Postmarketing reports: Hypersensitivity reactions including anaphylaxis, angioedema, rash, and urticaria[Ref]

Metabolic

Postmarketing reports: Hyperglycemia

Frequently asked questions

References

1. Cerner Multum, Inc. UK Summary of Product Characteristics.

2. Cerner Multum, Inc. Australian Product Information.

3. Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline. 2013.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.